1.Meta-analysis of Clinical Efficacy and Safety of Misoprostol versus Oxytocin in Preventing Postpartum Hemorrhage
Weizheng DONG ; Min DONG ; Haiyan CHEN ; Mengyan XU
China Pharmacy 2021;32(21):2655-2661
OBJECTIVE:To systematically evaluate the c linical efficacy and safety of misoprostol versus oxytocin in preventing postpartum hemorrhage ,and to provide evidence-based reference for clinical drug use. METHODS :Retrieved from CNKI,VIP,Wanfang database ,CBM,PubMed,Embase and the Cochrane Library ,randomized controlled trials (RCTs) published at home and abroad about clinical efficacy and safety of misoprostol and oxytocin in preventing postpartum hemorrhage were collected during the inception to Feb. 15th,2021. According to the inclusion and exclusion criteria ,the included studies were screened and evaluated. RevMan 5.3 software was used for Meta-analysis. RESULTS :A total of 14 RCTs involving 25 732 lying-in women were included. The results of Meta-analysis showed that compared with oxytocin group ,there was no difference in the mean blood loss (MD=14.96,95%CI(-2.62,32.54),P=0.10),the time of the third stage of labor (MD=-0.03,95%CI (-0.19,0.13),P=0.69),the incidence of blood transfusion (RR=0.91,95%CI(0.74,1.12),P=0.37)or the incidence of nausea(RR=1.06,95%CI(0.85,1.31),P=0.60)in misoprostol group ;but the incidence of shivering(RR=2.99,95%CI (2.22,4.04),P<0.000 01),the incidence of fever (RR=4.31,95%CI(2.79,6.67),P<0.000 01),the incidence of vomiting (RR=2.16,95%CI(1.63,2.88),P<0.000 01)and the incidence of diarrhea (RR=2.67,95%CI(1.79,3.98),P<0.000 01)in misoprostol group were higher. CONCLUSIONS :The effect of misoprostol in the prevention of postpartum hemorrhage is similar to oxytocin ,but the incidence of ADR is higher. It is necessary to pay close attention to the adverse reactions during use. Due to the limitation of included studies ,multi-center,large-scale and high-quality RCTs are needed for further validation.
2.Correlation between heart rate variability and psychological evaluation before blood donation
Luchuan WEI ; Yong WANG ; Xingnian CHEN ; Dong YANG ; Yun XIANG ; Weizheng GUAN ; Bo SHI ; Tian TIAN ; Shenglan WANG
Chinese Journal of Blood Transfusion 2024;37(3):331-337
【Objective】 To investigate the correlation between heart rate variability (HRV) and the degree of nervousness before blood donation. 【Methods】 The psychological state of 253 blood donors before blood donation was assessed by the self-rating anxiety scale (SAS) and the degree of nervousness and their HRV were measured. The correlation between the SAS score, the degree of nervousness and the HRV parameters was analyzed, and the differences were compared among different types of donors by multivariate linear regression. 【Results】 A total of 247 blood donors were included in the study. Five HRV parameters in blood donors aged 18-24 were higher than in those aged 25 years and above(all P<0.05), and the anxiety level was higher in female donors(SAS score 41-46) than in males(SAS score 35-43)(P<0.001); the pre-donation SAS score was consistent with the assessment of the tension level (r=0.970, P<0.001); the pre-donation tension level and the SAS score were all significantly negatively correlated with VLF in HRV parameters(r=0.179, P=0.005), and the associations were independent of confounders such as age, body mass index and gender (P<0.05). 【Conclusion】 Compared with SAS and tension assessment, HRV is more objective, and can be used as one of the tests for assessing the tension level of blood donors. The inclusion of HRV in the routine screening of blood donors deserves further study for its application in assessing the anxiety level of blood donors before blood donation, identifying people prone to blood donation-related vasovagal reaction (DRVR), preventing and reducing the risk of DRVR, and improving the safety of blood donation.